TY - JOUR
T1 - Detection of the SARS-CoV-2 humanized antibody with paper-based ELISA
AU - Kasetsirikul, Surasak
AU - Umer, Muhammad
AU - Soda, Narshone
AU - Sreejith, Kamalalayam Rajan
AU - Shiddiky, Muhammad J.A.
AU - Nguyen, Nam Trung
N1 - Publisher Copyright:
© The Royal Society of Chemistry.
PY - 2020/12/7
Y1 - 2020/12/7
N2 - This work reports the development of a rapid, simple and inexpensive colorimetric paper-based assay for the detection of the severe acute respiratory symptom coronavirus 2 (SARS-CoV-2) humanized antibody. The paper device was prepared with lamination for easy sample handling and coated with the recombinant SARS-CoV-2 nucleocapsid antigen. This assay employed a colorimetric reaction, which is followed by horseradish peroxidase (HRP) conjugated detecting antibody in the presence of the 3,3′,5,5′-tetramethylbenzidine (TMB) substrate. The colorimetric readout was evaluated and quantified for specificity and sensitivity. The characterization of this assay includes determining the linear regression curve, the limit of detection (LOD), the repeatability, and testing complex biological samples. We found that the LOD of the assay was 9.00 ng μL-1 (0.112 IU mL-1). The relative standard deviation was approximately 10% for a sample number of n = 3. We believe that our proof-of-concept assay has the potential to be developed for clinical screening of the SARS-CoV-2 humanized antibody as a tool to confirm infected active cases or to confirm SARS-CoV-2 immune cases during the process of vaccine development.
AB - This work reports the development of a rapid, simple and inexpensive colorimetric paper-based assay for the detection of the severe acute respiratory symptom coronavirus 2 (SARS-CoV-2) humanized antibody. The paper device was prepared with lamination for easy sample handling and coated with the recombinant SARS-CoV-2 nucleocapsid antigen. This assay employed a colorimetric reaction, which is followed by horseradish peroxidase (HRP) conjugated detecting antibody in the presence of the 3,3′,5,5′-tetramethylbenzidine (TMB) substrate. The colorimetric readout was evaluated and quantified for specificity and sensitivity. The characterization of this assay includes determining the linear regression curve, the limit of detection (LOD), the repeatability, and testing complex biological samples. We found that the LOD of the assay was 9.00 ng μL-1 (0.112 IU mL-1). The relative standard deviation was approximately 10% for a sample number of n = 3. We believe that our proof-of-concept assay has the potential to be developed for clinical screening of the SARS-CoV-2 humanized antibody as a tool to confirm infected active cases or to confirm SARS-CoV-2 immune cases during the process of vaccine development.
UR - http://www.scopus.com/inward/record.url?scp=85096815626&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096815626&partnerID=8YFLogxK
U2 - 10.1039/d0an01609h
DO - 10.1039/d0an01609h
M3 - Article
C2 - 32975254
AN - SCOPUS:85096815626
SN - 0003-2654
VL - 145
SP - 7680
EP - 7686
JO - Analyst
JF - Analyst
IS - 23
ER -